QuantumBlack, AI by McKinsey

AI consulting and delivery unit

QuantumBlack is McKinsey's AI arm. It combines AI development with process change and capability building; its Merck & Co. (MSD) project includes a clinical-document drafting application and changes to how teams use it.

Part of McKinsey & Company
Published pricing
Not statedRequest a scope-specific quote
Hourly rate
Not establishedNo matching rate established
Company size
Not establishedNot established in reviewed sources
Location · official
New York, USA; Singapore; Chicago, USAOfficial location / working model

Start with the work

Published AI projects

1 reviewed project · Source-linked

Published project 01

Merck & Co. (MSD)

Clinical study report authoring

Production / released (reported)

Agency contribution

McKinsey's account credits QuantumBlack's AI and data-science expertise in a jointly developed clinical-study-report authoring application, alongside process redesign, role changes and upskilling. Medical writers review the drafts.

Delivery scope & limits

Merck's 25 June 2025 release confirms an implemented platform and the first live clinical study report submissions earlier that year. Wider rollout was still planned; current coverage has not been independently checked.

Historical work · 2025

The client links to the McKinsey collaboration but does not separately identify QuantumBlack's contribution; the unit's role remains provider-attributed.

Medical writers retain oversight. Live report submissions do not establish regulatory acceptance, clinical efficacy or improved patient outcomes.

Reported productivity and error-reduction figures are not independently audited here. Planned broader rollout is not evidence of completed or current coverage.

Is this the right fit?

Services & project fit

For a project involving process redesign, AI application delivery, the linked work offers a starting point for a scope discussion.

  • Advises on AI adoption

Services supported by reviewed work

  • Process redesign
  • AI application delivery
  • Capability building

Group relationship

McKinsey & Company · AI arm

Official relationship source ↗

Plan the conversation

Pricing & company details

Commercial terms

Published pricing / project budget
Not stated in the reviewed sources
Hourly rate
Not established

Matching Clutch profile not found · Checked

An hourly band is not a scoped project quote.

Company & delivery

  • Company sizeNot established
  • Location · officialNew York, USA; Singapore; Chicago, USA

Matching Clutch profile not foundChecked

Official location / working model ↗ · Checked

Company-wide ranges and scale statements do not establish the size of your assigned delivery team.

How to interpret these listings

No matching Clutch profile was established during the company-name and official-domain checks. This means it was not found in this review; it does not prove that no profile exists. Parent-company or similarly named company figures have not been substituted.

Availability

Confirm with the agency

Know what the record supports

Evidence & sources

How we research →
Client / partner source

Evidence assessed

Merck & Co. (MSD) confirms the clinical-authoring platform and live report submissions in 2025, and links its co-development reference to McKinsey's account. That provider account credits QuantumBlack's contribution; the client does not separately itemize the unit's role. This corroborates the project and use stage, not an independent audit of performance or medical outcomes.

Assessment sources: Merck and McKinsey transform clinical authoring · Merck & Co.: internal generative-AI clinical authoring platform (June 2025)

Important limits

  • The client links to the McKinsey collaboration but does not separately identify QuantumBlack's contribution; the unit's role remains provider-attributed.
  • Medical writers retain oversight. Live report submissions do not establish regulatory acceptance, clinical efficacy or improved patient outcomes.
  • Reported productivity and error-reduction figures are not independently audited here. Planned broader rollout is not evidence of completed or current coverage.

Profile sources

  • Merck and McKinsey transform clinical authoringProject accountmckinsey.com · Checked

    corporate identity source · provider case study

    Company identity or group relationship Named project, QuantumBlack's role, process changes and human review.

    Historical retrieval note (8 November): Direct automated retrieval blocked; primary page content rechecked in research browser on 2026-11-08.

    Open original source ↗
  • QuantumBlack case studiesCompany sourcemckinsey.com · Checked

    provider case index

    Official unit and project portfolio.

    Open original source ↗
  • Merck & Co.: internal generative-AI clinical authoring platform (June 2025)Project accountMerck & Co., Inc. (MSD) · Checked

    client announcement · client project article

    Client confirms an implemented CSR-authoring platform and live report submissions in 2025. Describes medical-writer oversight and team training. Its co-development link targets the existing McKinsey case.

    Merck & Co. (MSD), not Merck KGaA.

    QuantumBlack's specific role is provider-attributed.

    Planned expansion does not establish current coverage.

    Open original source ↗
  • QuantumBlack people directoryCompany sourcemckinsey.com · Checked

    official company page

    Practitioner locations (examples): New York, USA; Singapore; Chicago, USA.

    Location or operating coverage is company-reported, not confirmation of the assigned delivery team.

    Open original source ↗

Evidence labels describe the reviewed documentation, not a quality rating or endorsement. Company-reported delivery and results are not an independent audit. How evidence labels work.

Before you shortlist

Questions to ask QuantumBlack, AI by McKinsey

  1. What concrete decisions and deliverables will the engagement produce?
  2. How will opportunities be prioritized against existing alternatives?
  3. Can you share a current reference, confirm availability and quote against our actual scope?

Suggest a correction